drugset / Trial / NCT00583063
Interaction Study of Rapamycin and Sunitinib in Patients With Advanced Cancers
RandomizedParallel-groupOpen-labelTreatment
Summary
Determine the pharmacokinetic interactions between rapamycin and sunitinib in patients with advanced solid tumors.
Timeline
- Start
- 2007-10
- Primary completion
- 2008-04
- Completion
- 2008-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Sirolimus | Small molecule | 4 mg | Oral |
| Subject | Sunitinib | Small molecule | 25 mg | Oral |